ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,099.16
-0.49%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Seagen Inc (SGEN)

  7. Seagen Inc (SGEN) 뉴스

SGEN Seagen Inc

228.74
0.00 (0.00%)
26 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Seagen Inc SGEN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 228.74 09:00:00
개장가 저가 고가 종가 전일 종가
228.74 228.74
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/01/202420:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
26/12/202320:12EDGAR2Form 15-12G - Securities registration termination [Section..
19/12/202308:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202307:25EDGAR2Form SC 13D/A - General statement of acquisition of..
16/12/202308:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202307:00PRNUSPADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA®..
14/12/202322:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
14/12/202322:29EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
14/12/202322:00EDGAR2Form 8-K - Current report
14/12/202322:00EDGAR2Form 25-NSE - Notification filed by national security..
12/12/202322:32EDGAR2Form 8-K - Current report
12/12/202321:43DJNPfizer to Close $43 Billion Seagen Acquisition This Week
11/12/202309:30BWADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy..
06/12/202322:15BWTUKYSA® (tucatinib) in Combination with Antibody-Drug..
01/12/202308:04DJNAstellas, Seagen: Cancer Treatment Padcev Supplemental..
01/12/202307:00BWFDA Grants Priority Review for Supplemental Biologics..
14/11/202311:37EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
14/11/202310:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202309:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202308:37EDGAR2Form 144 - Report of proposed sale of securities
10/11/202306:12EDGAR2Form 144 - Report of proposed sale of securities
04/11/202301:00BWSeagen Highlights First Solid Tumor Data for an ADCETRIS®..
03/11/202302:00BWNew Data for ADCETRIS® (brentuximab vedotin) with..
01/11/202321:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:09EDGAR2Form 8-K - Current report
01/11/202321:00BWSeagen Third Quarter 2023 Financial Results Reflect Strong..
22/10/202323:30PRNUSGroundbreaking EV-302 Trial Significantly Extends Overall..
20/10/202320:22IHMARKETNEWSFriday’s Wall Street Highlights: SolarEdge, Intuitive..
20/10/202300:14EDGAR2Form 8-K - Current report
16/10/202321:00BWSeagen to Highlight Overall Survival Data for PADCEV® and..
12/10/202321:00BWSeagen to Report Third Quarter 2023 Financial Results on..
23/09/202308:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/09/202308:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/09/202308:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/09/202308:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/09/202308:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/09/202320:02DJNMerck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits..

최근 히스토리

NASDAQ
SGEN
Seagen
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유